Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 6,282 | 83,014 | 1,226 | 0 | 268 |
| Operating Income | -6,282 | -83,014 | -1,226 | N/A | -268 |
| Interest Expense | 1,990 | 1,137 | 11 | 0 | 4 |
| Other Income | -59,840 | -3,611 | -14 | 0 | -18 |
| Pre-tax Income | -68,112 | -87,762 | -1,251 | 0 | -290 |
| Net Income Continuous | -68,112 | -87,762 | -1,251 | N/A | -290 |
| Net Income | $-68,112 | $-87,762 | $-1,251 | $N/A | $-290 |
| EPS Basic Total Ops | -9.30 | -13.11 | -0.19 | N/A | -0.04 |
| EPS Basic Continuous Ops | -9.30 | -13.11 | -0.19 | N/A | -0.04 |
| EPS Diluted Total Ops | -9.30 | -13.11 | -0.19 | N/A | -0.04 |
| EPS Diluted Continuous Ops | -9.30 | -13.11 | -0.19 | N/A | -0.04 |
| EBITDA(a) | $-6,118 | $-83,014 | $-1,226 | $N/A | $-268 |